Stockholm3 Detects 90% of Significant Prostate Cancers, Beating PSA's 74%

3 articles · Updated · Medical News Today · Jun 30

In a 12,600-man secondary analysis of the STHLM3-MRI trial, Stockholm3 identified 400 of 443 clinically significant prostate cancers over two years, versus 327 detected by PSA screening alone.
The tool matched PSA on specificity, suggesting it improved detection without materially increasing false positives or unnecessary follow-up referrals.
Stockholm3 combines PSA with genetic markers, four protein biomarkers, age, family history and other clinical factors to flag aggressive cancers that standard PSA thresholds can miss.
Researchers said the test could work as a first-line screen before MRI and biopsy, helping cut unnecessary procedures while preserving detection of cancers more likely to grow or spread.
Longer-term studies are still needed to show whether the stronger detection rate lowers advanced disease and prostate cancer deaths enough for broad screening-program adoption.

Sources

Medical News Today23h ago

Stockholm3 Tool Outperforms PSA for Clinically Significant Prostate Cancer Detection

Facebook23h ago

Stockholm3 blood test improves early detection of aggressive prostate cancer

LiveNOW from FOX23h ago

New blood test detects aggressive prostate cancer more accurately than PSA, study finds | LiveNOW from FOX

5 Sources

A new test detects 90% of serious prostate cancers. Why do men still get the old one that misses a quarter of them?

If a blood test can predict cancer risk using genetics, are universal screening guidelines for all men becoming obsolete?

Stockholm3 Outperforms PSA: Cutting Overdiagnosis and Mortality in Prostate Cancer Screening

Overview

Prostate cancer is a major health concern, and traditional screening methods often detect slow-growing cancers that do not need treatment, leading to unnecessary side effects. This highlights the urgent need for better tools that can tell the difference between aggressive and harmless cancers. The Stockholm3 test is a new scientific advancement designed to give a more precise risk assessment than older methods. By addressing the weaknesses of traditional screening, Stockholm3 helps doctors focus on finding cancers that truly need attention, improving early detection and patient outcomes while reducing unnecessary treatments.

...